vs
Nutex Health, Inc.（NUTX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
Nutex Health, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.3倍（$151.7M vs $117.7M），Nutex Health, Inc.净利率更高（7.8% vs -10.8%，领先18.6%），RESOURCES CONNECTION, INC.同比增速更快（-19.2% vs -41.1%），Nutex Health, Inc.自由现金流更多（$69.0M vs $15.6M），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs -11.8%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
NUTX vs RGP — 直观对比
营收规模更大
NUTX
是对方的1.3倍
$117.7M
营收增速更快
RGP
高出22.0%
-41.1%
净利率更高
NUTX
高出18.6%
-10.8%
自由现金流更多
NUTX
多$53.4M
$15.6M
两年增速更快
NUTX
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $117.7M |
| 净利润 | $11.8M | $-12.7M |
| 毛利率 | 30.4% | 37.1% |
| 营业利润率 | 20.4% | -10.3% |
| 净利率 | 7.8% | -10.8% |
| 营收同比 | -41.1% | -19.2% |
| 净利润同比 | -80.8% | 81.6% |
| 每股收益（稀释后） | $2.34 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRGP
| Q4 25 | $151.7M | $117.7M | ||
| Q3 25 | $267.8M | $120.2M | ||
| Q2 25 | $244.0M | $139.3M | ||
| Q1 25 | $211.8M | $129.4M | ||
| Q4 24 | $257.6M | $145.6M | ||
| Q3 24 | $78.8M | $136.9M | ||
| Q2 24 | $76.1M | $148.2M | ||
| Q1 24 | $67.5M | $151.3M |
净利润NUTXRGP
| Q4 25 | $11.8M | $-12.7M | ||
| Q3 25 | $55.4M | $-2.4M | ||
| Q2 25 | $-17.7M | $-73.3M | ||
| Q1 25 | $21.2M | $-44.1M | ||
| Q4 24 | $61.6M | $-68.7M | ||
| Q3 24 | $-8.8M | $-5.7M | ||
| Q2 24 | $-364.0K | $10.5M | ||
| Q1 24 | $-364.0K | $2.5M |
毛利率NUTXRGP
| Q4 25 | 30.4% | 37.1% | ||
| Q3 25 | 57.8% | 39.5% | ||
| Q2 25 | 51.2% | 40.2% | ||
| Q1 25 | 55.9% | 35.1% | ||
| Q4 24 | 55.0% | 38.5% | ||
| Q3 24 | 27.8% | 36.5% | ||
| Q2 24 | 29.7% | 40.2% | ||
| Q1 24 | 15.1% | 37.0% |
营业利润率NUTXRGP
| Q4 25 | 20.4% | -10.3% | ||
| Q3 25 | 48.7% | -1.7% | ||
| Q2 25 | 13.8% | -47.0% | ||
| Q1 25 | 38.1% | -38.4% | ||
| Q4 24 | 44.4% | -52.7% | ||
| Q3 24 | 12.3% | -3.5% | ||
| Q2 24 | 7.0% | 7.6% | ||
| Q1 24 | 2.1% | 2.8% |
净利率NUTXRGP
| Q4 25 | 7.8% | -10.8% | ||
| Q3 25 | 20.7% | -2.0% | ||
| Q2 25 | -7.3% | -52.6% | ||
| Q1 25 | 10.0% | -34.0% | ||
| Q4 24 | 23.9% | -47.2% | ||
| Q3 24 | -11.2% | -4.2% | ||
| Q2 24 | -0.5% | 7.1% | ||
| Q1 24 | -0.5% | 1.7% |
每股收益（稀释后）NUTXRGP
| Q4 25 | $2.34 | $-0.38 | ||
| Q3 25 | $7.76 | $-0.07 | ||
| Q2 25 | $-2.95 | $-2.21 | ||
| Q1 25 | $3.33 | $-1.34 | ||
| Q4 24 | $11.56 | $-2.08 | ||
| Q3 24 | $-1.72 | $-0.17 | ||
| Q2 24 | $-0.07 | $0.31 | ||
| Q1 24 | $-0.08 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $329.4M | $194.6M |
| 总资产 | $918.5M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXRGP
| Q4 25 | $185.6M | $89.8M | ||
| Q3 25 | $166.0M | $77.5M | ||
| Q2 25 | $96.7M | $86.1M | ||
| Q1 25 | $84.7M | $72.5M | ||
| Q4 24 | $40.6M | $78.2M | ||
| Q3 24 | $46.9M | $89.6M | ||
| Q2 24 | $40.8M | $108.9M | ||
| Q1 24 | $30.0M | $113.8M |
股东权益NUTXRGP
| Q4 25 | $329.4M | $194.6M | ||
| Q3 25 | $317.2M | $206.4M | ||
| Q2 25 | $235.3M | $207.1M | ||
| Q1 25 | $176.9M | $277.8M | ||
| Q4 24 | $132.4M | $325.7M | ||
| Q3 24 | $60.4M | $407.2M | ||
| Q2 24 | $62.7M | $418.8M | ||
| Q1 24 | $63.0M | $414.9M |
总资产NUTXRGP
| Q4 25 | $918.5M | $289.3M | ||
| Q3 25 | $964.5M | $287.2M | ||
| Q2 25 | $841.0M | $304.7M | ||
| Q1 25 | $761.9M | $375.6M | ||
| Q4 24 | $655.3M | $424.9M | ||
| Q3 24 | $438.5M | $512.9M | ||
| Q2 24 | $422.4M | $510.9M | ||
| Q1 24 | $404.3M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | $15.6M |
| 自由现金流率自由现金流/营收 | 45.5% | 13.2% |
| 资本支出强度资本支出/营收 | 0.9% | 0.3% |
| 现金转化率经营现金流/净利润 | 5.95× | — |
| 过去12个月自由现金流最近4个季度 | $245.6M | $24.3M |
8季度趋势，按日历期对齐
经营现金流NUTXRGP
| Q4 25 | $70.4M | $15.9M | ||
| Q3 25 | $99.5M | $-7.8M | ||
| Q2 25 | $27.3M | $16.8M | ||
| Q1 25 | $51.0M | $659.0K | ||
| Q4 24 | $54.0K | $1.8M | ||
| Q3 24 | $6.8M | $-309.0K | ||
| Q2 24 | $13.3M | $3.2M | ||
| Q1 24 | $3.1M | $20.5M |
自由现金流NUTXRGP
| Q4 25 | $69.0M | $15.6M | ||
| Q3 25 | $99.2M | $-8.0M | ||
| Q2 25 | $26.5M | $16.5M | ||
| Q1 25 | $50.9M | $238.0K | ||
| Q4 24 | $-341.0K | $61.0K | ||
| Q3 24 | $6.2M | $-575.0K | ||
| Q2 24 | $12.7M | $3.0M | ||
| Q1 24 | $2.3M | $20.4M |
自由现金流率NUTXRGP
| Q4 25 | 45.5% | 13.2% | ||
| Q3 25 | 37.0% | -6.6% | ||
| Q2 25 | 10.9% | 11.8% | ||
| Q1 25 | 24.0% | 0.2% | ||
| Q4 24 | -0.1% | 0.0% | ||
| Q3 24 | 7.8% | -0.4% | ||
| Q2 24 | 16.7% | 2.1% | ||
| Q1 24 | 3.4% | 13.5% |
资本支出强度NUTXRGP
| Q4 25 | 0.9% | 0.3% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.2% | 1.2% | ||
| Q3 24 | 0.8% | 0.2% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 1.1% | 0.1% |
现金转化率NUTXRGP
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
